<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>Philosophy, Ethics, and Humanities in Medicine - Latest articles</title>
		<link>http://www.peh-med.com</link>
		<description>The latest articles from Philosophy, Ethics, and Humanities in Medicine (ISSN 1747-5341) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.peh-med.com/content/3/1/17"/>			    
            
				    <rdf:li rdf:resource="http://www.peh-med.com/content/3/1/16"/>			    
            
				    <rdf:li rdf:resource="http://www.peh-med.com/content/3/1/15"/>			    
            
				    <rdf:li rdf:resource="http://www.peh-med.com/content/3/1/14"/>			    
            
				    <rdf:li rdf:resource="http://www.peh-med.com/content/3/1/13"/>			    
            
				    <rdf:li rdf:resource="http://www.peh-med.com/content/3/1/12"/>			    
            
				    <rdf:li rdf:resource="http://www.peh-med.com/content/3/1/11"/>			    
            
				    <rdf:li rdf:resource="http://www.peh-med.com/content/3/1/10"/>			    
            
				    <rdf:li rdf:resource="http://www.peh-med.com/content/3/1/9"/>			    
            
				    <rdf:li rdf:resource="http://www.peh-med.com/content/3/1/8"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.peh-med.com/content/3/1/17">
            
            <title>The anatomy of sorrow: a spiritual, phenomenological, and neurological perspective</title>
			<description>There is considerable controversy, both within and outside the field of psychiatry, regarding the boundaries of normal sadness and clinical depression. Furthermore, while there are frequent calls for a "pluralistic", comprehensive approach to understanding depression, few writers have tried to integrate insights from the spiritual, philosophical, and neurobiological literature. The author proposes that such a synthesis is possible, and that our understanding of ordinary sorrow and clinical depression is enriched by drawing from these disparate sources. In particular, a phenomenological analysis of sorrow and depression reveals two overlapping but distinct "lifeworlds". These differ in the relational, temporal, dialectical, and intentional realms. Recent brain imaging studies are also beginning to reveal the neurobiological correlates of sorrow and depression. As we come to understand the neurobiology of these states, we may be able to correlate specific alterations in "neurocircuitry" with their phenomenological expressions.</description>
			<link>http://www.peh-med.com/content/3/1/17</link>
			
			 	<dc:creator>Ronald Pies</dc:creator>
			
			<dc:source>Philosophy, Ethics, and Humanities in Medicine 2008, 3:17</dc:source>
			<dc:date>2008-06-17</dc:date>
			<dc:identifier>doi:10.1186/1747-5341-3-17</dc:identifier>
			
			
							
					<prism:publicationName>Philosophy, Ethics, and Humanities in Medicine</prism:publicationName>
					
			
							
					<prism:issn>1747-5341</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>17</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-17</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.peh-med.com/content/3/1/16">
            
            <title>The beginning of the end for chimpanzee experiments?</title>
			<description>The advanced sensory, psychological and social abilities of chimpanzees confer upon them a profound ability to suffer when born into unnatural captive environments, or captured from the wild &#8211; as many older research chimpanzees once were &#8211; and when subsequently subjected to confinement, social disruption, and involuntary participation in potentially harmful biomedical research. Justifications for such research depend primarily on the important contributions advocates claim it has made toward medical advancements. However, a recent large-scale systematic review indicates that invasive chimpanzee experiments rarely provide benefits in excess of their profound animal welfare, bioethical and financial costs. The approval of large numbers of these experiments &#8211; particularly within the US &#8211; therefore indicates a failure of the ethics committee system. By 2008, legislative or policy bans or restrictions on invasive great ape experimentation existed in seven European countries, Japan, Australia and New Zealand. In continuing to conduct such experiments on chimpanzees and other great apes, the US was almost completely isolated internationally. In 2007, however, the US National Institutes of Health National Center for Research Resources implemented a permanent funding moratorium on chimpanzee breeding, which is expected to result in a major decline in laboratory chimpanzee numbers over the next 30 years, as most are retired or die. Additionally, in 2008, The Great Ape Protection Act was introduced to Congress. The bill proposed to end invasive research and testing on an estimated 1,200 chimpanzees confined within US laboratories, and, for approximately 600 federally-owned, to ensure their permanent retirement to sanctuaries. These events have created an unprecedented opportunity for US legislators, researchers, and others, to consider a global ban on invasive chimpanzee research. Such a ban would not only uphold the best interests of chimpanzees, and other research fields presently deprived of funding, but would also increase the compliance of US animal researchers with internationally-accepted animal welfare and bioethical standards. It could even result in the first global moratorium on invasive research, for any non-human species, unless conducted in the best interests of the individual or species.</description>
			<link>http://www.peh-med.com/content/3/1/16</link>
			
			 	<dc:creator>Andrew Knight</dc:creator>
			
			<dc:source>Philosophy, Ethics, and Humanities in Medicine 2008, 3:16</dc:source>
			<dc:date>2008-06-02</dc:date>
			<dc:identifier>doi:10.1186/1747-5341-3-16</dc:identifier>
			
			
							
					<prism:publicationName>Philosophy, Ethics, and Humanities in Medicine</prism:publicationName>
					
			
							
					<prism:issn>1747-5341</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>16</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-02</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.peh-med.com/content/3/1/15">
            
            <title>
Malaria eradication in Mexico: Some historico-parasitological views on
 Cold war, deadly fevers by Marcos Cueto, Ph.D</title>
			<description>This review of Professor Marcos Cueto's Cold War Deadly Fevers: Malaria Eradication in Mexico, 1955&#8211;1975 discusses some of the historical, sociological, political and parasitological topics included in Dr. Cueto's superbly well-informed volume. The reviewer, a parasitologist, follows the trail illuminated by Dr. Cueto through the foundations of the malaria eradication campaign; the release in Mexico of the first postage stamp in the world dedicated to malaria control; epidemiological facts on malarial morbidity and mortality in Mexico when the campaign began; the emergence of problem areas that impeded eradication; considerations on mosquitoes and malaria transmission in Mexico; the role of business and society in malaria eradication; the results of the campaign; the relationship between malaria and poverty; and the parasitological lessons to be learned from the history of malaria eradication campaigns. Dr. Cueto's excellent and well-informed exploration of malaria &#8211; not merely as a disease but as a social, economic and human problem &#8211; makes this book required reading.</description>
			<link>http://www.peh-med.com/content/3/1/15</link>
			
			 	<dc:creator>Filiberto Malag&#243;n</dc:creator>
			
			<dc:source>Philosophy, Ethics, and Humanities in Medicine 2008, 3:15</dc:source>
			<dc:date>2008-06-02</dc:date>
			<dc:identifier>doi:10.1186/1747-5341-3-15</dc:identifier>
			
			
							
					<prism:publicationName>Philosophy, Ethics, and Humanities in Medicine</prism:publicationName>
					
			
							
					<prism:issn>1747-5341</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>15</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-02</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.peh-med.com/content/3/1/14">
            
            <title>Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?</title>
			<description>Antidepressants, in particular newer agents, are among the most widely prescribed medications worldwide with annual sales of billions of dollars. The introduction of these agents in the market has passed through seemingly strict regulatory control. Over a thousand randomized trials have been conducted with antidepressants. Statistically significant benefits have been repeatedly demonstrated and the medical literature is flooded with several hundreds of "positive" trials (both pre-approval and post-approval). However, two recent meta-analyses question this picture. The first meta-analysis used data that were submitted to FDA for the approval of 12 antidepressant drugs. While only half of these trials had formally significant effectiveness, published reports almost ubiquitously claimed significant results. "Negative" trials were either left unpublished or were distorted to present "positive" results. The average benefit of these drugs based on the FDA data was of small magnitude, while the published literature suggested larger benefits. A second meta-analysis using also FDA-submitted data examined the relationship between treatment effect and baseline severity of depression. Drug-placebo differences increased with increasing baseline severity and the difference became large enough to be clinically important only in the very small minority of patient populations with severe major depression. In severe major depression, antidepressants did not become more effective, simply placebo lost effectiveness. These data suggest that antidepressants may be less effective than their wide marketing suggests. Short-term benefits are small and long-term balance of benefits and harms is understudied. I discuss how the use of many small randomized trials with clinically non-relevant outcomes, improper interpretation of statistical significance, manipulated study design, biased selection of study populations, short follow-up, and selective and distorted reporting of results has built and nourished a seemingly evidence-based myth on antidepressant effectiveness and how higher evidence standards, with very large long-term trials and careful prospective meta-analyses of individual-level data may reach closer to the truth and clinically useful evidence.</description>
			<link>http://www.peh-med.com/content/3/1/14</link>
			
			 	<dc:creator>John PA Ioannidis</dc:creator>
			
			<dc:source>Philosophy, Ethics, and Humanities in Medicine 2008, 3:14</dc:source>
			<dc:date>2008-05-27</dc:date>
			<dc:identifier>doi:10.1186/1747-5341-3-14</dc:identifier>
			
			
							
					<prism:publicationName>Philosophy, Ethics, and Humanities in Medicine</prism:publicationName>
					
			
							
					<prism:issn>1747-5341</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>14</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-27</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.peh-med.com/content/3/1/13">
            
            <title>Review of Planning for uncertainty: living wills and other advance directives for you and your family, 2nd edition by David John Doukas, M.D., and William Reichel, M.D</title>
			<description>Advance directives are useful ways to express one's wishes about end of life care, but even now most people have not completed one of the documents. David Doukas and William Reichel strongly encourage planning for end of life care. Although Planning for Uncertainty is at times fairly abstract for the general reader, it does provide useful background and practical steps.</description>
			<link>http://www.peh-med.com/content/3/1/13</link>
			
			 	<dc:creator>Ellen W Bernal</dc:creator>
			
			<dc:source>Philosophy, Ethics, and Humanities in Medicine 2008, 3:13</dc:source>
			<dc:date>2008-05-22</dc:date>
			<dc:identifier>doi:10.1186/1747-5341-3-13</dc:identifier>
			
			
							
					<prism:publicationName>Philosophy, Ethics, and Humanities in Medicine</prism:publicationName>
					
			
							
					<prism:issn>1747-5341</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>13</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-22</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.peh-med.com/content/3/1/12">
            
            <title>Foucault's "fearless speech" and the transformation and mentoring of medical students</title>
			<description>In his six 1983 lectures published under the title, Fearless Speech (2001), Michel Foucault developed the theme of free speech and its relation to frankness, truth-telling, criticism, and duty. Derived from the ancient Greek word parrhesia, Foucault's analysis of free speech is relevant to the mentoring of medical students. This is especially true given the educational and social need to transform future physicians into able citizens who practice a fearless freedom of expression on behalf of their patients, the public, the medical profession, and themselves in the public and political arena. In this paper, we argue that Foucault's understanding of free speech, or parrhesia, should be read as an ethical response to the American Medical Association's recent educational effort, Initiative to Transform Medical Education (ITME): Recommendations for change in the system of medical education (2007). In this document, the American Medical Association identifies gaps in medical education, emphasizing the need to enhance health system safety and quality, to improve education in training institutions, and to address the inadequacy of physician preparedness in new content areas. These gaps, and their relationship to the ITME goal of promoting excellence in patient care by implementing reform in the US system of medical education, call for a serious consideration and use of Foucault's parrhesia in the way that medical students are trained and mentored.</description>
			<link>http://www.peh-med.com/content/3/1/12</link>
			
			 	<dc:creator>Thomas J Papadimos and Stuart J Murray</dc:creator>
			
			<dc:source>Philosophy, Ethics, and Humanities in Medicine 2008, 3:12</dc:source>
			<dc:date>2008-04-17</dc:date>
			<dc:identifier>doi:10.1186/1747-5341-3-12</dc:identifier>
			
			
							
					<prism:publicationName>Philosophy, Ethics, and Humanities in Medicine</prism:publicationName>
					
			
							
					<prism:issn>1747-5341</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>12</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-17</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.peh-med.com/content/3/1/11">
            
            <title>Review of "Ethics in Mental Health Research" by James M. DuBois</title>
			<description>The burgeoning field of medical ethics raises complicated questions for mental health researchers. The critical issues of risk assessment, beneficence, and the moral duties researchers owe their patients are analyzed in James DuBois's well written Ethics in Mental Health Research.</description>
			<link>http://www.peh-med.com/content/3/1/11</link>
			
			 	<dc:creator>Ronald Pies</dc:creator>
			
			<dc:source>Philosophy, Ethics, and Humanities in Medicine 2008, 3:11</dc:source>
			<dc:date>2008-04-03</dc:date>
			<dc:identifier>doi:10.1186/1747-5341-3-11</dc:identifier>
			
			
							
					<prism:publicationName>Philosophy, Ethics, and Humanities in Medicine</prism:publicationName>
					
			
							
					<prism:issn>1747-5341</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>11</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-03</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.peh-med.com/content/3/1/10">
            
            <title>Walking a mile in their patients' shoes: empathy and othering in medical students' education</title>
			<description>One of the major tasks of medical educators is to help maintain and increase trainee empathy for patients. Yet research suggests that during the course of medical training, empathy in medical students and residents decreases. Various exercises and more comprehensive paradigms have been introduced to promote empathy and other humanistic values, but with inadequate success. This paper argues that the potential for medical education to promote empathy is not easy for two reasons: a) Medical students and residents have complex and mostly unresolved emotional responses to the universal human vulnerability to illness, disability, decay, and ultimately death that they must confront in the process of rendering patient care b) Modernist assumptions about the capacity to protect, control, and restore run deep in institutional cultures of mainstream biomedicine and can create barriers to empathic relationships. In the absence of appropriate discourses about how to emotionally manage distressing aspects of the human condition, it is likely that trainees will resort to coping mechanisms that result in distance and detachment. This paper suggests the need for an epistemological paradigm that helps trainees develop a tolerance for imperfection in self and others; and acceptance of shared emotional vulnerability and suffering while simultaneously honoring the existence of difference. Reducing the sense of anxiety and threat that are now reinforced by the dominant medical discourse in the presence of illness will enable trainees to learn to emotionally contain the suffering of their patients and themselves, thus providing a psychologically sound foundation for the development of true empathy.</description>
			<link>http://www.peh-med.com/content/3/1/10</link>
			
			 	<dc:creator>Johanna Shapiro</dc:creator>
			
			<dc:source>Philosophy, Ethics, and Humanities in Medicine 2008, 3:10</dc:source>
			<dc:date>2008-03-12</dc:date>
			<dc:identifier>doi:10.1186/1747-5341-3-10</dc:identifier>
			
			
							
					<prism:publicationName>Philosophy, Ethics, and Humanities in Medicine</prism:publicationName>
					
			
							
					<prism:issn>1747-5341</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>10</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-03-12</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.peh-med.com/content/3/1/9">
            
            <title>Book review of Introduction to U.S. Health Policy: The Organization, Financing and Delivery of Health Care in America by Donald A. Barr</title>
			<description>Donald A. Barr's Introduction to U.S. Health Policy: The Organization, Financing, and Delivery of Health Care in America (second edition, 2007) offers a lucid and informative overview of the U.S. health system and the dilemmas policy makers currently face. Barr has provided a balanced introduction to the way health care is organized, financed, and delivered in the United States. The thirteen chapters of the book are quite comprehensive in the topics they cover. Even those knowledgeable about the U.S. health care system are likely to find much to stimulate their thinking in the text. The book can also appropriately serve as a basic text for a health policy course or in the medical or nursing school curriculum.</description>
			<link>http://www.peh-med.com/content/3/1/9</link>
			
			 	<dc:creator>Audrey R Chapman</dc:creator>
			
			<dc:source>Philosophy, Ethics, and Humanities in Medicine 2008, 3:9</dc:source>
			<dc:date>2008-03-03</dc:date>
			<dc:identifier>doi:10.1186/1747-5341-3-9</dc:identifier>
			
			
							
					<prism:publicationName>Philosophy, Ethics, and Humanities in Medicine</prism:publicationName>
					
			
							
					<prism:issn>1747-5341</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>9</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-03-03</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.peh-med.com/content/3/1/8">
            
            <title>Depression in an evolutionary context</title>
			<description>Sadness and low levels of depression are adaptive since they lead the individual to try and make up a loss. By contrast, severe or clinical depression is not adaptive, but can be thought of as sadness having become malignant.</description>
			<link>http://www.peh-med.com/content/3/1/8</link>
			
			 	<dc:creator>Lewis Wolpert</dc:creator>
			
			<dc:source>Philosophy, Ethics, and Humanities in Medicine 2008, 3:8</dc:source>
			<dc:date>2008-02-29</dc:date>
			<dc:identifier>doi:10.1186/1747-5341-3-8</dc:identifier>
			
			
							
					<prism:publicationName>Philosophy, Ethics, and Humanities in Medicine</prism:publicationName>
					
			
							
					<prism:issn>1747-5341</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>8</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-02-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
